eli lilly tirzepatide shortage launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Zepbound, Mounjaro back in supply

Nicotinamide mononucleotide (NMN) was excluded from the dietary supplement definition by FDA in 2022-2023 and remains in regulatory limbo for new dietary supplement marketing in the US

Emerging research links both drugs to non-arteritic anterior ischemic optic neuropathy (NAION), a condition that causes rapid and unexpected vision loss

Emerging research suggests that time-restricted eating patterns may influence metabolic health, though evidence remains preliminary

They urged researchers to dive deeper into the mechanism behind this correlation to better understand glaucoma pathology, hoping to develop novel management approaches toward the disease

Usually stabilizes